CN1579423A - 由蜂王浆和卵磷脂组成的复合物以及包括该复合物的营养组合物 - Google Patents
由蜂王浆和卵磷脂组成的复合物以及包括该复合物的营养组合物 Download PDFInfo
- Publication number
- CN1579423A CN1579423A CNA031524761A CN03152476A CN1579423A CN 1579423 A CN1579423 A CN 1579423A CN A031524761 A CNA031524761 A CN A031524761A CN 03152476 A CN03152476 A CN 03152476A CN 1579423 A CN1579423 A CN 1579423A
- Authority
- CN
- China
- Prior art keywords
- lac regis
- regis apis
- lecithin
- complex
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims description 18
- 229940109850 royal jelly Drugs 0.000 title abstract description 8
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 235000015097 nutrients Nutrition 0.000 title 1
- 229940067606 lecithin Drugs 0.000 claims abstract description 28
- 239000000787 lecithin Substances 0.000 claims abstract description 28
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 23
- 235000010445 lecithin Nutrition 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 13
- 239000002502 liposome Substances 0.000 description 9
- 239000008176 lyophilized powder Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- YJCJVMMDTBEITC-UHFFFAOYSA-N 10-hydroxycapric acid Chemical compound OCCCCCCCCCC(O)=O YJCJVMMDTBEITC-UHFFFAOYSA-N 0.000 description 4
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 3
- NTBLZMAMTZXLBP-UHFFFAOYSA-M 2-acetylsulfanylethyl(trimethyl)azanium;iodide Chemical compound [I-].CC(=O)SCC[N+](C)(C)C NTBLZMAMTZXLBP-UHFFFAOYSA-M 0.000 description 2
- XUNMWLWTZWWEIE-FNORWQNLSA-N 2E-decenedioic acid Chemical compound OC(=O)CCCCCC\C=C\C(O)=O XUNMWLWTZWWEIE-FNORWQNLSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- XUNMWLWTZWWEIE-UHFFFAOYSA-N dec-2t-enedioic acid Natural products OC(=O)CCCCCCC=CC(O)=O XUNMWLWTZWWEIE-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 1
- GFFIJCYHQYHUHB-UHFFFAOYSA-N 2-acetylsulfanylethyl(trimethyl)azanium Chemical compound CC(=O)SCC[N+](C)(C)C GFFIJCYHQYHUHB-UHFFFAOYSA-N 0.000 description 1
- FDMPSEJRQUANJF-UHFFFAOYSA-N 2-nitro-3,8-dithiatricyclo[5.1.0.02,4]oct-5-ene-4-carboxylic acid Chemical compound C12SC2C=CC2(C(=O)O)C1([N+]([O-])=O)S2 FDMPSEJRQUANJF-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- -1 antibacterial Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- LBJNMUFDOHXDFG-UHFFFAOYSA-N copper;hydrate Chemical compound O.[Cu].[Cu] LBJNMUFDOHXDFG-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000020603 homogenised milk Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Images
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031524761A CN1269485C (zh) | 2003-07-31 | 2003-07-31 | 由蜂王浆和卵磷脂组成的复合物以及包括该复合物的营养组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031524761A CN1269485C (zh) | 2003-07-31 | 2003-07-31 | 由蜂王浆和卵磷脂组成的复合物以及包括该复合物的营养组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1579423A true CN1579423A (zh) | 2005-02-16 |
CN1269485C CN1269485C (zh) | 2006-08-16 |
Family
ID=34579836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031524761A Expired - Fee Related CN1269485C (zh) | 2003-07-31 | 2003-07-31 | 由蜂王浆和卵磷脂组成的复合物以及包括该复合物的营养组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1269485C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108567729A (zh) * | 2018-07-20 | 2018-09-25 | 广州澳希亚实业有限公司 | 具有增加皮肤弹性及抗皱功能的化妆品组合物及其应用 |
CN108669509A (zh) * | 2018-03-21 | 2018-10-19 | 巢氏健康生物科技股份有限公司 | 一种新型含有10-hda脂质体的蜂王浆口服液及其制备方法 |
-
2003
- 2003-07-31 CN CNB031524761A patent/CN1269485C/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108669509A (zh) * | 2018-03-21 | 2018-10-19 | 巢氏健康生物科技股份有限公司 | 一种新型含有10-hda脂质体的蜂王浆口服液及其制备方法 |
CN108567729A (zh) * | 2018-07-20 | 2018-09-25 | 广州澳希亚实业有限公司 | 具有增加皮肤弹性及抗皱功能的化妆品组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1269485C (zh) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11083761B2 (en) | High potency stable formulations of vaginal Lactobacillus | |
CN1480528A (zh) | 双歧杆菌和含有它们的制品 | |
JPH02207756A (ja) | 畜産業における飼料要求率を改良するための添加剤としての溶菌酵素生成物およびプロテアーゼの使用 | |
Furmanowa et al. | Rosavin as a product of glycosylation by Rhodiola rosea (roseroot) cell cultures | |
JP2005520515A (ja) | セレン酵母製品、セレン酵母製品を調製する方法、および食品、栄養補助食品または薬剤を調製するための製品の使用 | |
CN1269485C (zh) | 由蜂王浆和卵磷脂组成的复合物以及包括该复合物的营养组合物 | |
KR102541470B1 (ko) | 버섯 유래 키토산을 이용한 가축 및 반려동물용 음수첨가제 및 이의 제조방법 | |
PT87141B (pt) | Processo para a preparacao de composicoes de ascomicetos, esquizomicetos e leveduras transformadas biofisicamente, e de racoes e nutrientes vegetais contendo estas composicoes | |
EP0363491B1 (fr) | Preparation bacterienne pour prophylaxie et traitement de processus inflammatoires et d'affections allergiques | |
Shittu | Activities of alkaline phosphatase, glutamate oxaloacetate transaminase and glutamate pyruvate transaminase in liver and serum of T. brucei–infected rats treated with honey. | |
CN108338362A (zh) | 一种乳清多肽螯合亚铁生物补铁剂及其制备方法 | |
CA2575905A1 (en) | Nutritional ingredient containing bioavailable mineral nutrients | |
JP4305785B1 (ja) | プリン体吸収抑制剤及び血中尿酸値低減剤 | |
Güven et al. | Effect of fluoride intoxication on lipid peroxidation and reduced glutathione in Tuj sheep | |
Miltko et al. | Can fungal zoospores be the source of energy for the rumen protozoa Eudiplodinium maggii? | |
JP2973053B2 (ja) | 魚類用餌料性疾患治療・予防剤 | |
RU2225215C2 (ru) | Применение пропионовокислых бактерий для образования пропионовой кислоты и/или пропионатов в ободочной кишке | |
RU2190015C1 (ru) | Штамм lactobacillus brevis ba-13, используемый для приготовления пробиотических препаратов и продуктов питания | |
CN117264850B (zh) | 一种具有辅助治疗阴道炎和增强免疫力功能的戊糖片球菌sw006及其应用 | |
CN115252671B (zh) | 仙人掌果花色苷在制备调控肠道菌群产品中的应用 | |
CN115137017B (zh) | 一种植物精油饲料添加剂及其应用 | |
TWI730719B (zh) | 植物醱酵物及其製造方法、含彼之組成物暨其用途 | |
CN109043224A (zh) | 一种减少食用贝类体内镉富集的净化剂 | |
CN1127917C (zh) | 一种延缓衰老的功能性营养保健品 | |
SK288782B6 (sk) | Probiotický prípravok, spôsob jeho prípravy a použitie probiotického prípravku |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NONE WUXI RUINIAN INDUSTRY CO.,LTD. Free format text: FORMER OWNER: RUINIAN BIOLOGICAL SCIENCE-TECHNOLOGY CO., LTD., WUXI Effective date: 20060901 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060901 Address after: 214092 Liang Liang Road, Taihu National Tourism Resort, Jiangsu, Wuxi, China Patentee after: WUXI RUINIAN INDUSTRY CO., LTD. Address before: Liang Lu Mei Mei Mashan 214092 Jiangsu city of Wuxi Province West Bridge Beam Patentee before: Ruinian Biological Science-Technology Co., Ltd., Wuxi |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Jiangsu ruinian forward Pharmaceutical Co. Ltd. Assignor: WUXI RUINIAN INDUSTRY CO., LTD. Contract fulfillment period: 2009.3.28 to 2023.3.1 Contract record no.: 2009320000978 Denomination of invention: Compound comprised royal jelly and nutrient composition comprising said compound Granted publication date: 20060816 License type: General permission Record date: 20090604 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: COMMON LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.3.28 TO 2023.3.1; CHANGE OF CONTRACT Name of requester: JIANGSU RUINIAN QIANJIN PHARMACEUTICAL CO., LTD. Effective date: 20090604 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Nanjing ruinian bestsunny Pharmaceutical Co. Ltd. Assignor: WUXI RUINIAN INDUSTRY CO., LTD. Contract record no.: 2011320000045 Denomination of invention: Compound comprised royal jelly and nutrient composition comprising said compound Granted publication date: 20060816 License type: Exclusive License Open date: 20050216 Record date: 20110218 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Nanjing ruinian bestsunny Pharmaceutical Co. Ltd. Assignor: WUXI RUINIAN INDUSTRY CO., LTD. Contract record no.: 2011320000045 Date of cancellation: 20140529 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060816 Termination date: 20200731 |